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ABSTRACT 
Catatonia is a clinical syndrome associated with a wide variety of psychiatric, medical and 
neurological disorders. Despite several reports in the literature of a wide range of medical and 
neurological diseases causing catatonia, there has been a tendency to consider catatonia as purely 
osychiatric disorder. The review attempts to look at the concept of organic catatonia from a histori-
cal viewpoint, including its place in the psychiatric classification, discusses the various etiological 
causes of organic catatonia, and them goes through some important management issues in organic 
catatonia. The review suggests that organic catatonic disorder must be first considered in every 
patient with catatonic signs, particularly in a patient with new onset catatonia. 
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There has been a tendency to consider 
r catatonia as a purely psychiatric disorder, despite 
many case reports demonstrating a wide range 
of medical and neurological diseases, as well 
as psychiatric causes, associated with catatonic 
symptomatology (Barnes et al, 1986, Clark & 
Rickards, 1999a). The common occurrence of 
catatonic symptoms in schizophrenia has in fact 
diminished, with most catatonic symptoms 
presenting now in association with either mood 
disorders or general medical conditions (Blumer, 
1997). Actually, few phenomena in psychiatry 
or neurology are as enigmatic as catatonia (Lohr 
& Wisniewski, 1987). This is partly due to the 
many contradictions surrounding the concept of 
catatonia. Catatonia has been variously 
described as a disease (Kahlbaum, 1874), a 
syndrome (Gelenberg, 1976), a non-specific 
symptom (Peralta et al ,1997), a subtype of 
schizophrenia (Kraepelin, 1919; Bleuler, 1950), 
and as a symptom seen more commonly in mood 
disorders (Abrams & Taylor, 1976). Strangely 
enough, it is both caused as well as ameliorated 
by neuroleptics (Lohr & Wisniewski, 1987). 
Historical perspective : In a science 
beleaguered by a plethora of soft signs and 
absence of demonstrable physical signs, 
catatonia appears to be one of the more 
"medical" appearing conditions in psychiatry The 
debate regarding whether catatonia constitutes 
a disease entity or merely a conglomeration of 
signs and symptoms was almost nipped in the 
bud by Kahlbaum, when he christened catatonia 
as a "symptom complex" (Ahuja, 2000). 
Karl Ludwig Kahlbaum first described 
catatonia (meaning, "to stretch tightly") (Johnson, 
1993) in 1868 during a lecture and later published 
his work in a small monograph, "The Tonic 
Mental Disorder or the Tension Insanity" (English 
Translation 1973) To clarify the issue further, 
his pupil Hecker (1871) wrote that "to consider 
these symptomatological patterns as diseases 
would be the same as to consider, in somatic 
medicine, headache, chest pain, and abdominal 
pain as disease entities." It is, however, to be 
noted that after describing catatonia as a 
"symptom complex", Kahlbaum went beyond the 
mere conglomeration of signs and symptoms, 
and actually paid a lot of emphasis on the entire 
"disease" process and "course" of the illness. In 
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Kahlbaum's opinion, he had described a distinct 
entity of equal importance to GPI, but with better 
prognosis. He stressed that catatonia was often 
associated with affective illness (mood disorder), 
occurring in both mania and depression. He also 
gave examples of other diseases that are 
associated with catatonia, namely alcoholism, 
epilepsy, malaria, syphilis, post-partum states, 
post-traumatic states, and tuberculosis (though 
the tuberculosis in his cases may well have been 
due to long periods of debilitation) (Barnes et al, 
1986). 
His autopsy studies showed abnormalities 
in the vicinity of the Sylvian fossa, and of the 
second and third frontal gyrus, i.e. in the area 
already known as the site of speech formation. 
Kahlbaum judged this finding noteworthy with 
regard to the clinical symptoms of mutism and 
verbigeration so prominent in catatonia, but he 
justly considered his findings as preliminary 
(Blumer, 1997). He was convinced that ultimately 
the etiology of catatonia lay in an "anato-mico-
pathological" (sic) change in the brain. He 
believed that the patients could die of catatonia. 
The fatal form of catatonia was later termed as 
"lethal catatonia" by Stauder in 1934. Although 
believing firmly in the "organic" etiology of 
catatonia, Kahlbaum also recognized the 
existence of psychogenic as well epidemic forms 
of catatonia. 
The book on catatonia passed relatively 
unnoticed until 1896, when Emil Kraepelin 
incorporated catatonia (as well as hebephrenia) 
as a subtype of dementia praecox (later termed 
as schizophrenia by Eugene Bleuler). This 
amalgamation had a major influence on the 
future of the term "catatonia", it being regarded 
as a purely psychiatric condition, commonly 
associated with schizophrenia Kraepelin also put 
forward a psychological interpretation (as did 
Eugene Bleuler later) of the catatonic phenomena 
as being due of 'mental blocking". This was a 
direct antithesis of Kahlbaum's view of catatonia 
as an organic disease However, surprisingly both 
Kraepelin and Bleuler recognized that catatonia 
can occur secondary to a variety of other 
functional and organic disorders, but this fact has 
not been given much publicity 
The historical association of catatonia with 
chronic schizophrenia has often engendered a 
feeling of therapeutic nihilism. Barnes et al. 
(1986) have therefore recommended that 
catatonia be called as "Kahlbaum's syndrome" 
to honour the man who so accurately described 
the disorder over a century ago. That catatonia 
is a syndrome with multiple etiologies is brilliantly 
illustrated in the landmark article by Gelenberg 
(1976) where he described the catatonic 
syndrome. In fact this article by Gelenberg, and 
another by Abrams and Taylor (1976), laid the 
foundation for the origin of the concept of 
"Organic catatonic syndrome" (Ahuja & Nehru, 
1989). Though Gelenberg (1976) was one of the 
first to list the several causes of catatonia, since 
then many more associations have been 
published. Recently, there has been an 
emergence of realization that neuroleptic 
malignant syndrome (NMS) may also be another 
form of catatonia (Ahuja & Nehru, 1990; White 
& Robins,1992, Fink et al.,1993). 
It has been suggested that the prevalence 
of catatonia has decreased over time (Mahendra, 
1981), at least in the developed countries. 
Although the prevalence of catatonia is supposed 
to be much lower in the developed countries as 
compared to developing ones. Carroll & Spetie 
(1994) found 1.6% of all patients on a 
consultation-liaison service met "restrictive 
criteria" for catatonic disorder Rosebush et al. 
(1990) found an even higher figure of 9% (of all 
admissions), again using strict criteria (requiring 
four or more signs for diagnosis). Catatonic signs 
and symptoms are found in 7-14% (Ungvari et 
al, 1994; Bush et al. 1996a) of all new psychiatric 
admissions in some other studies These findings 
support the theory that catatonia is often under-
recognized and under-diagnosed. According to 
Fink et al. (1993), catatonia appears in many 
guises and is often difficult to diagnose The 
more dramatic features are uncommon, 
encouraging the belief that catatonia has become 
rare. Several authors have found that a 
significant percentage (20-39%) of catatonic 
patients suffer from organic catatonia (Barnes 
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^et al.,1986; Wilcox, 1986, Bush et al , 1996a). 
More prior brain injury and physical illness at 
onset was found in catatonic patients (Wilcox, 
1986). 
Organic catatonia and classification: In 
ICD-9, DSM-III and DSM-III-R, catatonia was 
categorized only as a subtype of schizophrenia, 
following the tradition of Kraepelin and Bleuler. 
It has been pointed out that catatonia should be 
separated from schizophrenia in the psychiatric 
nomenclature and that organic catatonia should 
be classified separately (Ahuja & Nehru, 1989; 
Fink & Taylor, 1991) 
DSM-IV includes catatonia as a specifier 
for mood disorders ("with catatonic features") and 
as a separate disorder ("catatonic disorder due 
to general medical condition"), in addition to a 
subtype of schizophrenia. The diagnostic criteria 
for "catatonic disorder due to general medical 
condition" include presence of catatonia (as 
manifested by motoric immobility, excessive 
r motor activity that is apparently purposeless and 
not influenced by external stimuli, extreme 
negativism or mutism, peculiarities of voluntary 
movement, or echolalia or echopraxia). The 
criteria require evidence from history, physical 
examination, or laboratory findings that the 
disturbance is a direct physiological 
consequence of a general medical condition, and 
the disturbance is not better accounted for by 
another mental disorder (e.g. manic episode). 
The disturbance should not occur exclusively 
during the course of delirium. 
The "organic catatonic disorder" (F06.1) 
is described in both versions of ICD-10, CDDG 
(Clinical Descriptions and Diagnostic Guidelines) 
and DCR (Diagnostic Criteria for Research), 
though the DCR criteria are more stringent. In 
• addition to the condition that the general criteria 
for F06 ("Other mental disorders due to brain 
damage and dysfunction and to physical 
disease") are met, the ICD-10 requires the 
presence of stupor and/or negativism, and 
catatonic excitement, with rapid alteration 
between stupor and excitement The confidence 
m the diagnosis is increased by the presence of 
additional catatonic phenomena (e.g. 
stereotypies, waxy flexibility). The DCR criteria 
also stress on the need to exclude delirium 
before diagnosing organic catatonic disorder. 
The inclusion of organic catatonia in DSM-
IV and ICD-10 will help in better recognition and 
diagnosis of catatonic symptomatology. As 
mentioned earlier, catatonic signs are perhaps 
the only "real" objective signs in psychiatry. 
Attempts have therefore been made to examine 
these signs by using rating scales, so as to 
objectively quantify the severity of the disorder. 
Early identification of catatonic features is 
important as the symptoms may require specific 
treatment with benzodiazepines and/or ECT 
(Bushetal, 1996b; Rosebush et al , 1990). The 
various rating scales available for catatonia 
include Bush-Francis Catatonia Rating Scale and 
a shorter Bush-Francis Catatonia Screening 
Instrument (Bushetal., 1996a), Modified Rogers 
Scale, Lohr and Wismewski's scale (1987), 
Northoff Catatonia Scale (Northoff et al., 1999b), 
and Catatonia Rating Scale (Braunig et al., 2000). 
Etiology: Any review of literature on 
catatonia can not fail to be struck by the diversity 
of etiologies of catatonia Acute catatonic 
syndrome is a condition that can be caused by a 
variety of metabolic, neurological, psychiatric, 
and toxic conditions, including neuroleptic 
malignant syndrome. The neurological causes 
of catatonia include a variety of lesions that may 
affect any level of the central nervous system 
from the brain stem to the cerebral hemispheres 
(Patterson, 1986) 
The first attempts to simulate catatonia 
experimentally were made iri laboratory animals 
in the beginning of 20th century. DeJong induced 
catatonia in laboratory in 1945, the first 
experimental model psychosis to be produced. 
In his book. "Experimental Catatonia", he 
described 23 different methods of inducing 
catatonia in primates, e.g. bulbocapnine, 
mescaline, cannabis, CO, and production of 
Eck's fistula (anastomosing the inferior vena 
cava and the portal vein) In DeJong's view, 
catatonia was similar to epilepsy, a general 
neurological reaction of the central nervous 
system to a specific toxin. According to Taylor 
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(1990), catatonia is a state phenomenon. It results 
from dysfunction of the brain's motor regulation 
centres, is not the result of permanent structural 
brain changes, and regardless of co-occurring 
symptoms, resolves quickly with treatment. 
The neurochemical and neuroanatomical 
basis of catatonia remains unknown, though 
several theories exist. It seems that several 
neurotransmitters are critical in causation of 
catatonia. Dopaminergic pathways are 
implicated because of several reasons. Drugs, 
that are either dopamine depleters or are 
antidopaminergic, are associated with 
occurrence of catatonia as well as NMS. 
Neuroleptics that block dopamine can worsen 
catatonia and may precipitate NMS, particularly 
in catatonic patients (White & Robins, 1992; 
Koch et al., 2000) GABA-ergic systems too have 
been implicated, keeping in view the 
effectiveness of benzodiazepines in the 
treatment of catatonia (including NMS) There 
is evidence that GABA regulates dopamine 
activity in the mesolimbic and mesostriatal 
systems (Fricchione et al., 1983). 
Benzodiazepines, acting as GABA facilitators, 
probably alleviate a dopamine blockade in the 
mesostriatal and mesolimbic systems, thereby 
stimulating the motor systems and releasing the 
inhibited catatonic behaviour (Salam et al., 
1987). Northoff et al. (1996) have suggested that 
the different subtypes of catatonia may represent 
dysfunction of different neurotransmitter 
systems. The dyskinetic subtype (with high CPK) 
may signify GABA-ergic dysfunction, with good 
response to lorazepam. The parkinsonic subtype 
(with low CPK) may indicate dopaminergic 
disturbance in the cortico-striatal-thalamo-
cortical circuit (the so-called motor loop), with a 
poor response to lorazepam. The 
neuroanatomical localization of catatonia can be 
inferred from the various medical and 
neurological disorders that cause catatonic signs. 
1. Neurological disorders 
Organic catatonic disorder occurs due a 
variety of neurological disorders, mostly affecting 
the basal ganglia, limbic system, frontal and 
temporal lobes, and diencephalon Northoff et 
al. (1999a) conducted a functional Magnetic 
Resonance Imaging (fMRI) study in two catatonic 
patients as compared to healthy controls. They 
found decreased activation in contralateral motor 
cortex during a motor task (sequential finger 
opposition), along with evidence of disturbance 
of hemispheric localization of activity. However, 
the patients were diagnosed as catatonic 
schizophrenia and schizoaffective disorder, and 
whether the findings were due to the catatonic 
state or underlying disorder, was not clear. Their 
earlier SPECT study (Northoff et al, 1997; cited 
in Northoff et al, 1999a) on a large number of 
catatonics showed decrease of r-CBF in right 
fronto-parietal cortex. In another study, Northoff 
et al. (1999c) found decreased density of 
GABA-A receptors in the left sensorimotor cortex 
and right parietal cortex in akinetic catatonia. 
This finding is important keeping in mind the 
good response of "akinetic" catatonia to 
lorazepam and other benzodiazepines, which act 
on GABA-A receptor. 
A. Brain stem, diencephalic, and basal ganglia 
disorders: One of the recurring themes in the 
etiology of organic catatonia (as well as akinetic 
mutism) is the lesions in and around the III 
ventricle. These include traumatic haemorrhage 
in III ventricle (Newmann,1955). epidermoid cyst 
III ventricle (Cairns,1941), thalamotomy and 
thalamic lesions (Kleist.1960), subthalamic 
mesencephalic tumours (Neumann, 1996), and 
neoplasms involving III ventricle (Newmann, 
1955). Hoenig and Toakley (1959) reported a 
patient with recurrent stupor presenting as a 
"mixed neurotic illness", who was found to have 
a craniopharyngioma pressing on the brain stem, 
on autopsy. Globus pallidus lesions, either 
bilateral (Mettler,1955) or focal (Kleist, 1960), 
parkinsonism (Mettler.1955; Patterson, 1986), 
especially atherosclerotic parkinsonism 
(Brain, 1962), neoplasms and space occupying 
lesions, and dystonia (Carroll et al. 1994) may 
also be associated with catatonic features. 
Chemical lesions of caudate (particularly bilateral 
and extensive) in animals can produce catatonia 
(Spiegel & Szekely, 1961) However, if the 
amygdala or the amygdala-stnatal pathway is 
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k destroyed prior to the caudate lesion, catatonia 
can no longer be produced. It is interesting to 
note that amygdala, under conditions of extreme 
fear and arousal, can produce catatonic-like 
frozen states, including waxy flexibility, 
presumably by acting on the stratum and SMA 
(supplementary motor area). Similarly, massive 
bilateral lesions of caudate and anterior putamen 
have been known to produce catatonic features 
(Joseph. 1996). 
B. Frontal lobe disorders Catatonia has also 
been thought to be a manifestation of frontal lobe 
lesions (Kleist, 1960; Taylor, 1990). Kretschmer 
supported this view and called the condition as 
apallic syndrome (Johnson. 1993). Freeman and 
Watts (1942) described development of waxy 
flexibility, catatonia, and related symptoms after 
a gunshot wound, in which the bullet passed 
completely through the frontal lobes. Similarly, 
Hillbom (1951) reported frontal lobe injuries due 
to missile wounds with catatonic features. This 
view is supported by occurrence of catatonic 
signs in frontal lobe lesions, like frontal lobe 
contusion (Rommel, 1998), frontal lobe atrophy 
(Ruff, 1980), and neoplasms and space occupying 
lesions in frontal lobe Deep medial lesions of the 
frontal lobe, particularly those involving the SMA 
(supplementary motor area), may give rise to 
emotional blunting, decreased speech output or 
mutism, perseveration, severe apathy, posturing 
and catatonic-like symptoms (like gegenhalten 
and waxy flexibility) (Joseph, 1996). 
C. Parietal lobe disorders: Lesions of parietal 
lobe too can lead to organic catatonia, like 
bipanetal infarct (Ttppin & Dunner, 1981 Howards 
& Low-Beer, 1989), right hemispheric infarct, 
mostly involving parietal lobe [presenting with 
only left-sided posturing and left hemineglect 
(Saver et al.,1993)], arachnoid cyst in right 
parietal lobe (Wolaczyk et al.,1997), and 
neoplasms and space occupying lesions in the 
parietal lobe. As mentioned above. Northoff et 
al. (1999c) found (right) parietal cortex to be of 
Importance in causation of catatonia 
D. Limbic and temporal lobe disorders: There 
are several reports of appearance of catatonia 
in lesions affecting the limbic system (especially 
the cingulated gyrus and its connections to the 
frontal lobe) and the temporal lobe The reported 
lesions include temporal lobe infarct (Malamud 
&Boyd. 1929). focal temporal encephalomaiacia 
(Sours, 1962). septum pellucidum tumours 
(impinging on fornix) (De Morsier, 1968), 
neoplasms and space occupying lesions, and 
limbic encephalitis. 
E. Generalized CNS disorders Many times, 
catatonia can occur due to diffuse brain 
pathology, such as closed head injury and diffuse 
brain trauma (Sutter et al ,1959), dementia 
(Valenstein et al ,1985), diffuse cerebral atrophy, 
and multiple sclerosis (Mathews, 1979; Pine et 
al.,1995; Mendez.1999). 
F. Infections: Catatonic states occur in both the 
acute and post-encephalitic states of encephalitis 
lethargica (Tilney & Howe. 1920. Cheyette & 
Cummings,1995, Dekleva & Husain.1995; 
Johnson & Lucey.1987), and may develop quite 
independently of any psychotic symptoms 
(Davison & Bagley,1969). The amyostatic-
akinetic form of encephalitis lethargica was the 
third most common form in the 1918 epidemic, 
and was known as "epidemic stupor" (Johnson 
& Lucey,1987). In this disorder catatonic signs 
and obsessive symptoms may often co-exist. 
Recently, several reports have appeared in 
literature of appearance of catatonic signs tn HIV 
encephalopathy or AIDS dementia (Volkow et 
al.,1987, Scamvougeras & Rosebush,1992; 
Carroll etal., 1994; Broughetal ,2000) Catatonic 
symptomatology can occur in presence of 
encephalitis both viral and bacterial 
Among tne viral e; cepnantis (Wison, 
1976, Glaser & Pmcus 1969; herpes (Raskin & 
Frank,1974), chicken pox (Blau & Averbuck, 
1936), encephalitis lethargica, atypical viral 
hemorrhagic tick-borne encephalitis (Abczynska 
& Terminska,1995), and rabies (Prabhakar et al,, 
1992) have been associated with catatonia, while 
the bacterial meningo-encephalitis (Orland & 
Daghestani.1987) have included borrelia 
burgdorferi encephalitis (Neumarker etal ,1989; 
Pfister et al.,1993). and acute Chagas' 
encephalitis (Sevlever et al .1987; The other 
infections include hydatid disease (Brage et al., 
331 NIRAJ AHUJA 
1956), post-immunization encephalopathy (Kim 
& Perlstein, 1970), subacute sclerosing 
panencephalitis (Koehler & Jakumeit.1976), 
neurosyphilis and GPI (Kahlbaum,1874; Herman 
et al., 1942), progressive multifocal 
leukoencephalopathy (Carroll et al.,1994), and 
encephalomyelitis disseminate (Boerner.1996). 
In developing countries, malaria (Durrant,1977), 
tuberculosis (Kahlbaum,1874), and typhoid 
(Breakey & Kala,1977; Skrabanek,1977) are 
important, though under-recognized, causes of 
•organic catatonia. 
G. Epilepsy: The association of epilepsy with 
catatonia has been pointed out repeatedly 
(Gomez et al ,1982, Lim et al.,1986; Primavera 
et al.,1994), beginning with the original work of 
Kahlbaum. Kanemoto et al.(1999) described ictal 
catatonia as a manifestation of de novo absence 
status epileptics, following benzodiazepine 
withdrawal in a 78 year old patient. In addition 
to the fixed and glassy-eyed stare, the patient 
exhibited waxy flexibility, which responded to re-
administration of benzodiazepines. Thompson 
& Greenhouse (1968) and Gomez et al. (1982) 
have also described catatonic signs in 
association with absence status (Petit mal 
status) Lim et al. (1986) reported 3 cases of 
ictal catatonia, a non-convulsive status 
epilepticus, which responded dramatically to IV 
phenytoin Primavera et al. (1994) stressed on 
the importance of EEG in detection of seizure 
activity in patients with acute catatonic 
syndrome. Organic catatonia has also been 
described in patients with complex partial 
epilepsy (Kirubakaran et al.,1987; Walls et al., 
1993), post-ictal state, "spike-wave" stupor, and 
psychomotor status (Kramer, 1977; Shah & 
Kaplan. 1980) 
H. Miscellaneous neurological disorders: 
Cerebrovascular lesions, like cortical venous 
thrombosis (Gangadhar et al., 1983), 
subarachnoid haemorrhage (Hanson & Brown, 
1973; Thompson,1970; Solomon,1978), 
subdural hematoma (Woods, 1980; Jain et al., 
1993). and bacillar aneurysms, AVM of posterior 
cerebral vessels and ACA aneurysms, may also 
present with catatonia. Degenerative lesions 
[e.g. cerebro-macular degeneration, hereditary 
cerebellar ataxia (Folkerts et al..1998). and 
central pontine myelinolysis (Chalela & Kattah, 
1999)] and neoplasms (Furtado & Freitas.1946; 
De Morsier,1968; Steriade et al.,1961) [e.g. 
pinealoma, and craniopharyngioma (Hoenig & 
Toakley,1959), and paraneoplastic 
encephalopathy (Tandon et al .1988)] may also 
be associated with catatonic signs. Other 
disorders which can cause catatonia, include 
cerebral lupus erythematosus (Kronfol et 
al.,1977; Fricchione et al.,1990) and non-
cerebral lupus erythematosus (Daradkeh & 
Nasrallah,1987), hydrocephalus (Foltz & Ward, 
1956), narcolepsy (Cave.1931). tuberous 
sclerosis (Critchley & Earl, 1932). Wilson's disease 
(Akil et al., 1991, Davis & Borde, 1993). Tay-Sach's 
disease (Rosebush etal., 1995). and Prader-Willi 
syndrome (Dhossche & Bouman.1997). 
II. Metabolic, Systemic and Endocrine Disorders 
Gjessing (1976) conducted metabolic 
studies in periodic catatonia (a rare disorder 
described by Kraepelin). The disorder is 
characterized by episodes of cataleptic states 
alternating with mental excitement He showed 
that during the cataleptic state there was nitrogen 
retention, which he attributed to the accumulation 
of a toxic substance He advocated treatment 
with large doses of thyroid extract, in an attempt-
to stimulate catabolism of the toxin. Several 
other metabolic derangements can cause 
catatonic symptomatology. These include 
diabetic keto-acidosis (Katz, 1934). homocystinuria 
(Freeman et al., 1975), hypercalcemia, e.g. 
secondary to parathyroid adenoma (Cooper & 
Schapira,1973), acute intermittent porphyria 
(Freeman & Kolb,1951), hereditary 
coproporphyria (Offenstadt et al . 1980). hepatic 
failure (Jaffe,1967), renal failure (Carroll et 
al.,1994), membranous glomerulonephritis, and 
hyponatremia (Lee & Schwartz. 1997) 
Among the endocrine disorders, catatonia 
has been described with hypothyroidism, 
hyperthyroidism (Farah & McCall,1995), 
hyperparathyroidism (Cooper & Schapira, 1973), 
and adrenal carcinoma (Steinberg.1996) 
III. Nutritional Deficiency 
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The nutritional causes of catatonia include 
pellagra (Gelenberg,1976), nicotinic acid 
deficiency (Teare et al., 1993), Wernicke's 
encephalopathy (Teare et al., 1993), and Vitamin 
B12 deficiency (Catalano et al.,1998). 
IV. Drugs and Toxic Agents 
Catatonic signs can occur both during 
intoxication as well as withdrawal from drugs of 
dependence. Some reported cases include: 
alcohol intoxication (Bender & Schilder, 1933), 
opiates, e.g. morphine (Enquist et al.,1980), 
glutethamide withdrawal (Good, 1976; Campbell 
et al.,1983), amphetamines (Warner & 
Pierozynski,1977; Chern & Tsai,1993), e.g. 
methylphenidate (Janowsky etal.,1973), MDMA 
intoxication (Maxwell et al.,1993; Lee,1994), 
cannabis (Warner & Pierozynski,1977), 
mescaline intoxication (Gjessing,1976), LSD 
intoxication, phencyclidine intoxication 
(Baldridge & Bessen,1990), benzodiazepine 
withdrawal (Hauser et al., 1989; Rosebush & 
Mazurek,1996), and isopropyl alcohol poisoning 
(Wiernikowskietal.,1997). They have also been 
reported with disulfiram (Reisberg,1978; 
Weddington et al.,1980; Fisher, 1989; 
Schmuecker,1992). 
Neuroleptics have long been used for the 
treatment of catatonic schizophrenia, as well as 
catatonia occurring in other disorders (like mood 
disorders). However, neuroleptics have also 
been reported to cause catatonic symptoms, 
particularly in high doses (May, 1959; Gelenberg 
& Mandel,1977; Weinberger & Kelly,1977; 
Fricchione et al.,1983; Taylor,1990; Bush et al., 
1996b; Blumer,1997; Clark & Rickards, 1999b). 
Recently, catatonia has been reported with 
atypical antipsychotics like risperidone (Bahro 
et al.,1999), though in a patient with frontal 
lobotomy. Neuroleptics are also associated with 
the occurrence of NMS, which has been recently 
thought to be a subtype of catatonia (Ahuja & 
'Nehru, 1989). Patients with present or past 
catatonic symptoms are particularly vulnerable 
to NMS (Blumer,1997). Multiple catatonic signs 
are present in NMS and the severity of NMS 
predicts the number of catatonic signs (Koch et 
al,2000).-Lethal (or pernicious or malignant) 
catatonia is now considered clinically inseparable 
from NMS (Ahuja & Nehru, 1989, Koch et al., 
2000), although not all workers agree with this 
view (Castillo et al.,1989). 
Intoxication with pharmacological agents, 
such as aspirin (Herman et al.,1942), lithium, 
NMDA antagonists (Lees,1997), baclofen 
(Pauker & Brown, 1986), and steroids/ACTH 
(Sullivan & Dickerman,1979; Fink,1991), may 
cause catatonic features. In other cases, 
anticonvulsants (Sher et al ,1983), gabapentin 
withdrawal (Rosebush et al.,1999), antibiotics, 
e.g. ciprofloxacin (Akhtar & Ahmad, 1993), 
bupropion (Jackson et al.,1992), allopurinol 
(Collins et al., 1991) and levodopa 
(Barbeau,1972) have been incriminated. Toxic 
agents, like fluorinated hydrocarbons 
[illuminating gas (Schwab & Barrow, 1964)], coal 
gas (Herman et al.,1942) and CO poisoning, can 
also cause catatonia. Bulbocapine was used by 
DeJong (1945) to produce experimental 
catatonia in cats. 
V. Miscellaneous Disorders 
Catatonia has also been described to 
occur secondary to electrocution, burns (Zarr & 
Nowak,1990), toxic epidermal necrolysis (Lyell 
syndrome) (Weller et al.,1992), ligation of 
hepatic artery and portocaval anastomoses, 
autoimmune disorders (Lichtenstein et al ,1989, 
Nasierowski & Piotrowski, 1997), hepatic amebiasis 
(Suner-Churlaud et al.,1992), and thrombotic 
thrombocytopenic purpura (Read, 1983). 
VI. Psychiatric Disorders 
Of course, apart from the organic causes, 
catatonia can also occur in various psychiatric 
disorders These disorders include schizophrenia, 
mood disorders (Taylor & Abrams,1977), 
dissociative/conversion disorders (Gelenberg, 
1976; Ungvari et al ,1994), OCD (Hermesh, 
1989), reactive psychosis, acute and transient 
psychotic disorder (Banerjee & Sharma,1995; 
Payee et al.,1999), postpartum/puerperal 
catatonia (Bach-y-Rita & De Ranieri,1992; 
Ranzini et al.,1996), PTSD (Shiloh et al ,1995), 
and under hypnosis (Kornfeld,1985). Catatonic 
signs are also seen in autistic disorder (pervasive 
developmental disorder) (Dhossche,1998; Zaw 
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et al.,1999) and autism spectrum disorders 
(Wing & Shah,2000). Autistic disorder shares 
some symptoms with catatonia, namely mutism, 
echopraxia and echolalia, and stereotypies 
(Realmuto & August, 1991). Little is written of the 
association of autism and catatonia to clarify the 
possibility of catatonia as a variant or as a sign 
of a comorbid condition. 
Benegal et at. (1993) have described an 
idiopathic variety of catatonia, encompassing 
those patients with catatonia who can not be 
fitted into the existing classification systems. 
Some Management Issues: In the 
management of catatonia, particularly organic 
catatonic disorder, it is important to treat at the 
earliest. Catatonia is associated with excess 
early mortality when it is unrecognized or 
inadequately treated (McCall et al.,1995). 
Catatonic patients were more likely to die of 
pulmonary embolism, particularly after the 
second week of appearance of catatonic 
symptoms and often occurred without warning 
(McCall et al.,1995). Prompt resolution of the 
catatonic syndrome with benzodiazepines, 
barbiturates, or electroconvulsive therapy is the 
best way to reduce risk of pulmonary embolism, 
in addition to risks of infection and other medical 
complications. Also, prompt resolution of 
catatonic symptoms (like mutism and 
negativism) allows the clinician to obtain a more 
detailed information from the patient, necessary 
for correct diagnosis and management. 
Since 1930, amobarbital (amytal) and 
other barbiturates have been used effectively 
(Bleckwenn,1930) for producing temporary 
improvement in catatonic symptoms, allowing 
for feeding and for interviewing the patient There 
were also some reports of temporary relief from 
catatonic symptoms by the use of stimulants like 
amphetamines. Traditionally, amytal or pentothal 
interview was used to differentiate between 
organic and functional catatonic stupor, and it 
also helped in ameliorating, even though 
transiently, the functional catatonic stupor 
(Gelenberg,1976; McCall et al ,1992). The 
organic stupor seemed to deteriorate, or not 
improve, with the intravenous use of these short-
acting barbiturates. However, recently lorazepam 
has been shown to be effective in producing a 
beneficial response even in catatonia with 
organic etiology (Fricchione et al., 1983, 
Rosebush et al.,1990), though not all authors, 
agree (Salam & Kilzieh, 1988). The safer 
benzodiazepines have virtually replaced the 
barbiturates for the diagnosis and acute 
management of catatonic syndrome, though 
rigorous, controlled studies comparing 
amobarbital with placebo and benzodiazepines 
in specific patient populations are needed 
(Kavirajan,1999). 
Hawkins et al. (1995) reviewed the recent 
literature and found that the most commonly 
reported treatment for catatonia was with 
benzodiazepines. Lorazepam exhibited the 
highest frequency of use and a 79% complete 
response rate The usual dose is 1-2 mg IV (or 
IM) and 3-6 mg/day orally. The initial positive 
response to IV lorazepam may predict the final 
response of catatonia to oral lorazepam (Bush 
etal.,1996). Payee etal. (1999), in the only study 
till date of the use of lorazepam in catatonia from 
our country, also found the usefulness of 
lorazepam in non-organic catatonia. Although 
treatment of catatonia should be based on the 
underlying cause of catatonia, when identifiable 
(Ahuja,1988), lorazepam appears to be a safe 
and effective first-line treatment of acute 
catatonia. In addition, there are now several 
reports of use of lorazepam and diazepam in 
the treatment of NMS (Koch et al ,2000). Its use 
in chronic catatonic states has, however, been 
doubted (Ungvari et al.,1999). Favourable 
reports of use of other benzodiazepines, like 
diazepam (the first report of a benzodiazepine 
use in catatonia) (McEvoy & Lohr,1984), 
midazolam (DeLisle,1991; Morena et al.,1994) 
and oxazepam (Schmider et al.,1999), in 
retarded catatonia have also been described. 
Smith & Lebegue (1991), however, did not find 
clonazepam to be effective in a catatonic patient, 
where lorazepam was found useful 
Similar to amytal test, Zolpidem (7.5-10 
mg) has been used for transient amelioration of 
catatonic symptoms, sometimes when arjiytal 
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has failed (Zaw and Bates, 1997) or even 
lorazepam and ECT have failed (Mastain et al., 
1995; Thomas et al.,1997). GABA-A agonists 
enhance GABA activity that may reverse 
abnormal basal ganglia dopaminergic activity 
which has been postulated to explain the motor 
abnormalities of catatonia (Thomas et al., 1997). 
In Hawkins et al. (1995) review, 
antipsychotics demonstrated poor efficacy in 
treatment of catatonia. In fact, neuroleptics may 
exacerbate catatonia (Gelenberg & Mandel, 
1977; Fricchioneetal.,1983; Taylor, 1990; Bush 
et al., 1996b; Clark & Rickards, 1999b). It has also 
been shown that catatonia may be a risk factor 
for the development of NMS, when neuroleptic 
drugs are administered (White & Robins, 1991). 
32% of the catatonic patients in one series (Bush 
et al, 1996b) did not even have any psychosis, 
further supporting the need to avoid neuroleptics 
in catatonic patients. A conservative approach 
would be to discontinue neuroleptics whenever 
lethal catatonia or NMS is suspected. IV 
antidepressants (like clomipramine) have also 
been found useful by some in the treatment of 
catatonia associated with mood disorders 
(Barroso et al.,1999). There are occasional 
reports of improvement of catatonia with 
carbamazepine (Rankel & Rankel,1988) and 
lithium (Pheterson et al.,1985). 
The efficacy of ECT in the management 
of catatonia is impressive (Fink etal.,1993). It is 
no surprise that both Meduna (for camphor 
treatment in 1934) and Cerletti and Bihi (for ECT 
•treatment in 1938) selected catatonic patients 
for their initial treatments; catatonic stupor for 
camphor treatment and catatonic excitement for 
ECT treatment.(Fink, 1984; Bush et al. 19961 
Hawkins et al. (1995) found ECT to be efficacious 
in catatonia (85%) and found it to provide a 
positive outcome in cases of malignant 
catatonia. ECT should be considered when rapid 
resolution is necessary (e.g., malignant 
catatonia) or when an initial lorazepam trial fails 
(Hawkins et al.,1995; Bush et al, 1996b; Yeung 
et al.,1996). A favorable outcome can be 
expected when ECT is started early, provided 
the underlying pathological process is treatable 
and there are no structural lesions in the central 
nervous system. Several instances of good 
response of ECT in organic catatonia have been 
described in the literature. Among-theses include 
cases of catatonia secondary to encephalitis 
lethargica (Dekleva & Husain,1995), 
hyperthyroidism (Farah & McCall,1995), typhoid 
(Breakey & Kala, 1977). lupus erythematosus 
(Fricchione et al., 1990), hereditary cerebellar 
ataxia (Folkerts et al.,1998), toxic epidermal 
necrolysis (Weller et al.,1992) and NMS (Trailer 
& Sachdev,1999). 
In conclusion, catatonia is a clinical 
syndrome associated with a wide variety of 
psychiatric, medical and neurological disorders. 
As Gelenberg (1976) said, it "...is not a rare 
phenomenon; does not automatically imply a 
'functional' disorder; and certainly does not 
always indicate schizophrenia." The physicians 
and psychiatrists are advised to be aware of 
firstly, the presence of catatonic signs in a variety 
of disorders (Carroll et al.,1994) and secondly, 
the potentially serious organic illnesses which 
may underlie the catatonic syndrome (Talbot-
Stern et al.,2000). Catatonic disorder due to 
general medical condition (or Organic catatonic 
disorder) must be first considered in every patient 
with catatonic signs, particularly in a patient with 
new onset catatonia. In addition to a careful 
psychiatric and medical history (including history 
of drug use), and a detailed neurological, medical 
and psychiatric examination, diagnostic 
procedures, like CT and MRI should be used, if 
indicated by the patient's history Like 
hypertension or parkinsonism, catatonia 
discovered on physical examination should spur 
a medical investigation to uncover the probable 
cause (Gelenberg, 1976) 
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